About Seungho Lee
Seungho Lee is co-founder, chief executive officer and a director of SUTOL Bio. The company develops a monthly capsule that releases medicine for more than 30 days.
A biomedical engineer, Lee co-invented SUTOL’s stomach-resident technology in MIT’s Langer and Traverso labs. He spent more than six years turning that research into a monthly oral platform. His work includes 20 patents and more than 45 peer-reviewed publications.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Seungho Lee in the role, so the role may have started earlier or lasted longer.
Sutol Bio, Inc. Current
Co-Founder & CEO, director
2026 – Present · Cambridge, MA
SUTOL Bio develops a stomach-resident capsule that releases medicine continuously for more than 30 days.
Key Colleagues at Startups
The people Seungho Lee works with at each company, as listed on that company's latest Form D.
Sutol Bio, Inc. · Form D, Nov 10, 2026
Matt Murphy
Co-Founder & Chief Engineer, director
Carlo Traverso
Co-Founder & Scientific Advisor, director
Robert Langer
Co-Founder & Scientific Advisor, director